Pfizer
- PFE
- NYSE
- Consumer Products
- Latest 29.16
- Currency US$
- Change 0.07
- Percent Change 0.241 %
- Volume 152,088,553
- Mon Jun 17, 2013 4:00 PM EDT NYSE data delayed 15 minutes.
The Globe and Mail
- Open 29.40
- Previous Close 29.09
- High 29.40
- Low 28.90
- Bidx0 29.20
- Askx0 29.28
- 52-week High 04/23 31.15
- 52-week Low 07/11 22.00
- Beta 0.722
- Market Cap 209,533.55M
- EPS 2.08
- P/E 20.68
- Forward P/E 12.569
- PEG 3.06
- Annual Dividend 0.96
- Yield 3.292
News
- Teva, Sun Pharma to pay $2.15-billion to settle ‘milestone’ Pfizer patent suit
- Big Pharma consolidation not thrilling investors
- Muddle-through earnings season won’t hold back stocks
- US STOCKS-S&P 500, Nasdaq rise; market eyes 3rd week of gains
- US STOCKS-Wall St little changed as commodity sector weighs
- Zoetis Set to Join S&P 500; First Horizon National to Join S&P MidCap 400; QLogic to Join S&P SmallCap 600
- Pfizer Obtains $2.15 Billion Settlement from Teva and Sun for Infringement of Protonix® Patent
- Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
- Pfizer Chooses UnitedLex to Manage Document Review Services
- Americans Believe Their Communities Are Ill-Prepared For Aging Population, New Survey Reveals; Survey Shows A Fear Of Getting Old Due To Health And Financial Concerns
Financials & Calendars
- Sales $57,601,000,000
- Earnings $15,526,000,000
- Return on Equity 18.87%
- Cash Flow --
- Cash $2,134,000,000
- Current Ratio 2.35
12 months ended Mar 31, 2013.
Trailing 12 month results shown above.
All data is in U.S. dollars.
- Assets $187,398,000,000
- Liabilities $104,571,000,000
- Liabilities-to-Equity Ratio 1.26
Price Ratios
- Price to Sales 3.64
- Price to Book 2.53
- Price to Cash Flow n/a
Event Calendar
| Event | Last | Next | ||
|---|---|---|---|---|
| Earnings | Apr 30 | $0.55 | Aug 6 | $0.56 |
| Surprises | Apr 30 | -1.82% | n/a | n/a |
| Dividends | May 8 | $0.24 | n/a | n/a |
| Splits | n/a | -- | n/a | n/a |
12 months ended Jun 18, 2013.
A look at major corporate events and financial announcements that are coming up.
Company Information
About the Company
Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and consumer healthcare products. Pfizer's Animal Health business unit discovers, develops and sells products for the prevention and treatment of diseases in livestock and companion animals. It sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. is headquartered in New York.
Officers
- Ian C. Read Chairman and Chief Executive O
- Olivier Brandicourt President and General Manager
- Company Type: n/a
- Company Status: n/a
- Full-time Employees: n/a
-
Incorporation:
United States,
n/a -
Top 1000 Ranking:
Profit: n/a
Revenue: n/a
Assets: n/a
Ideas & Discussion
Live Discussion of PFE on StockTwits